Giant lymph node hyperplasia (castleman's disease) with spontaneous production of high levels of b‐cell differentiation factor activity
暂无分享,去创建一个
E. Ishii | A. Komiyama | J. Fujimoto | T. Murata | T. Akabane | H. Kawai | A. Yabuhara | M. Yanagisawa | Masafumi Itoh | Junji Hata
[1] M. Yanagisawa. Analysis of Killer Cell Activities in Epstein‐Barr Virus Infections , 1987, Acta paediatrica Japonica : Overseas edition.
[2] Y. Ueyama,et al. Differentiation antigens defined by mouse monoclonal antibodies against human germ cell tumors. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[3] W. Fiers,et al. B cell growth modulating and differentiating activity of recombinant human 26‐kd protein (BSF‐2, HuIFN‐beta 2, HPGF). , 1987, The EMBO journal.
[4] T. Taniguchi,et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.
[5] S. Akira,et al. Effect of B cell differentiation factor (BCDF) on biosynthesis and secretion of immunoglobulin molecules in human B cell lines. , 1985, Journal of immunology.
[6] J. D. Marshall,et al. Novel B-cell maturation factor from spontaneously autoimmune viable motheaten mice. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[7] V. Desmet,et al. Distribution of lymphocyte subsets in a case of angiofollicular lymph node hyperplasia. , 1984, American journal of clinical pathology.
[8] T. Takami,et al. Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies. , 1984, Clinical and experimental immunology.
[9] T. Kishimoto,et al. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. , 1984, Journal of immunology.
[10] T. M. Fieser,et al. B Cell‐Tropic Interleukins in Murine Systemic Lupus Erythematosus (SLE) 1 , 1984, Immunological reviews.
[11] T. Kishimoto,et al. T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. , 1981, Journal of immunology.
[12] R. Braylan,et al. Immunological markers and DNA content in a case of giant lymph node hyperplasia (Castleman's disease) , 1980, Cancer.
[13] B. Dupont,et al. Benign giant lymphoid hyperplasia of the mediastinum with associated abnormalities of the immune system. , 1974, The Journal of pediatrics.
[14] B. Castleman,et al. Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locations , 1972, Cancer.
[15] B. Castleman,et al. Localized mediastinal lymph‐node hyperplasia resembling thymoma , 1956, Cancer.
[16] T. Hirano,et al. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[17] W. Paul,et al. Regulation of B-cell growth and differentiation by soluble factors. , 1983, Annual review of immunology.
[18] Y. Miyagawa,et al. Demonstration of T lymphocytotoxic human fetal antibody against maternal T and concanavalin A‐inducible adult T cells in cord IgM , 1981, European journal of immunology.
[19] K. Tung,et al. Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature , 1967, Cancer.